Anhui Fengyuan Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014X5
CNY
6.80
0.51 (8.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Net Sales has grown by an annual rate of 4.32% and Operating profit at 2.92% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 7.81% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of 4.32% and Operating profit at 2.92% over the last 5 years

 
3

With a fall in Net Sales of -8.59%, the company declared Very Negative results in Mar 25

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 2,851 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.57%

stock-summary
Debt Equity

0.54

stock-summary
Return on Equity

5.94%

stock-summary
Price to Book

1.36

Revenue and Profits:
Net Sales:
1,077 Million
(Quarterly Results - Jun 2025)
Net Profit:
38 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.58%
0%
12.58%
6 Months
1.04%
0%
1.04%
1 Year
21.21%
0%
21.21%
2 Years
-1.24%
0%
-1.24%
3 Years
13.88%
0%
13.88%
4 Years
6.01%
0%
6.01%
5 Years
24.44%
0%
24.44%

Anhui Fengyuan Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.32%
EBIT Growth (5y)
2.92%
EBIT to Interest (avg)
4.90
Debt to EBITDA (avg)
2.86
Net Debt to Equity (avg)
0.54
Sales to Capital Employed (avg)
1.38
Tax Ratio
20.12%
Dividend Payout Ratio
28.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.31%
ROE (avg)
7.81%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
1.36
EV to EBIT
31.56
EV to EBITDA
14.27
EV to Capital Employed
1.23
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
1.57%
ROCE (Latest)
3.91%
ROE (Latest)
5.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -8.59% vs 10.20% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -28.05% vs -7.42% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,077.40",
          "val2": "1,178.70",
          "chgp": "-8.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "80.30",
          "val2": "98.50",
          "chgp": "-18.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.80",
          "val2": "8.10",
          "chgp": "-3.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "-7.70",
          "chgp": "146.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.70",
          "val2": "52.40",
          "chgp": "-28.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.20%",
          "val2": "54.00%",
          "chgp": "-1.68%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.30% vs 6.72% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.25% vs 4.24% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,250.70",
          "val2": "4,237.90",
          "chgp": "0.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "323.00",
          "val2": "338.60",
          "chgp": "-4.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "31.30",
          "val2": "34.60",
          "chgp": "-9.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.30",
          "val2": "-6.90",
          "chgp": "23.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "157.70",
          "val2": "157.30",
          "chgp": "0.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.50%",
          "val2": "47.10%",
          "chgp": "-0.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
1,077.40
1,178.70
-8.59%
Operating Profit (PBDIT) excl Other Income
80.30
98.50
-18.48%
Interest
7.80
8.10
-3.70%
Exceptional Items
3.60
-7.70
146.75%
Consolidate Net Profit
37.70
52.40
-28.05%
Operating Profit Margin (Excl OI)
37.20%
54.00%
-1.68%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -8.59% vs 10.20% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -28.05% vs -7.42% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,250.70
4,237.90
0.30%
Operating Profit (PBDIT) excl Other Income
323.00
338.60
-4.61%
Interest
31.30
34.60
-9.54%
Exceptional Items
-5.30
-6.90
23.19%
Consolidate Net Profit
157.70
157.30
0.25%
Operating Profit Margin (Excl OI)
42.50%
47.10%
-0.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.30% vs 6.72% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 0.25% vs 4.24% in Dec 2023

stock-summaryCompany CV
About Anhui Fengyuan Pharmaceutical Co., Ltd. stock-summary
stock-summary
Anhui Fengyuan Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available